Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04250584
Other study ID # BAH001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2020
Est. completion date June 2021

Study information

Verified date January 2020
Source BioAnalytics Holdings Pty Ltd
Contact Cyril Jones
Phone +61 419 594 572
Email cjones@bioanalytics.com.au
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is a thirty three week, prospective, open-label, randomized, parallel-group non-inferiority study.

The study aims to investigate the Substantial Equivalence of a novel mandibular device called iSlpr™, produced by BioAnalytics, to a currently approved device, SomnoDent® Classic, in the treatment of mild to moderate Obstructive Sleep Apnoea (OSA) and snoring.


Description:

The objective of this study is to determine if the BioAnalytics device, iSlpr™, has a similar safety and efficacy profile to a commonly used device, SomnoDent® Classic, in the treatment of snoring and mild to moderate Obstructive Sleep Apnoea.

The target population will be males and females aged from 18 years to less than 75 years, who have been diagnosed with snoring and mild to moderate sleep apnoea.

Participants will remain on study from screening visit to end of study visit; a total of approximately 33 weeks.

This study includes -

- a screening period of up to 28 days

- a 2 week device initiation period

- a 24 week treatment period


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 66
Est. completion date June 2021
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- 18 years or older and younger than 75 years at time of screening

- Snoring and mild to moderate sleep apnoea ( AHI > 5 and < 30 per hr)

- Written informed consent

- Able to complete the study procedures within the study timeline.

Exclusion Criteria:

- Women who are pregnant or breast-feeding

- Central sleep apnoea

- Severe respiratory disorders

- Loose teeth or advanced periodontal disease

- Lateral bruxers

- Full or partial dentures

- Temporomandibular Joint (TMJ) abnormalities, pain or dysfunction

- Other teeth, jaw or gum disorders would preclude use of the device

- Cardiovascular comorbidities or stroke/heart attack in past 12 months

- Drug-addiction

- Major Depressive Disorder or psychosis

- Undergoing concomitant therapy for OSA/Snoring

- current or previous therapy with SomnoDent Classic

- Professional drivers or machine operators required to be undertaking CPAP

Study Design


Related Conditions & MeSH terms


Intervention

Device:
iSlpr™
mandibular advancement device
SomnoDent® Classic
mandibular advancement device

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
BioAnalytics Holdings Pty Ltd

Outcome

Type Measure Description Time frame Safety issue
Primary AHI Apnea Hypopnea Index 24 weeks
Primary ODI Oxygen Desaturation Index 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT03919955 - A Novel Pharmacological Therapy for Obstructive Sleep Apnea Phase 2
Completed NCT03927547 - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Completed NCT02188498 - Electrocardiography Data Analysis in Sleep Disorders
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00747890 - Surgical Treatment of Mild Obstructive Sleep Apnea N/A
Active, not recruiting NCT00738179 - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease Phase 3
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Completed NCT00202501 - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome N/A
Completed NCT00047463 - Effects of Treating Obstructive Sleep Apnea in Epilepsy Phase 2
Not yet recruiting NCT06029881 - Portable System for Non-intrusive Monitoring of Sleep
Recruiting NCT06093347 - Central Apnoea Monitor Study
Terminated NCT05445869 - Severe OSA Study (SOS) N/A
Withdrawn NCT04096261 - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting NCT04575740 - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea N/A
Completed NCT04676191 - Validation of a Contactless Vital Signs Measurement Sensor N/A
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed NCT06051097 - Metabolic Syndrome and Obstructive Sleep Apnea
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury